110 related articles for article (PubMed ID: 12574960)
1. Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis.
Yeh SP; Chiu CF; Lo WJ; Lin CL; Hsueh CT; Liao YM; Shen YC
Ann Hematol; 2003 Jan; 82(1):24-9. PubMed ID: 12574960
[TBL] [Abstract][Full Text] [Related]
2. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
[TBL] [Abstract][Full Text] [Related]
3. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
Gil L; Styczynski J; Komarnicki M
Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
[TBL] [Abstract][Full Text] [Related]
4. Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.
Chandrasekar PH; Abraham OC; Klein J; Alangaden G; Chalasani G; Cassells L; Dansey R; Abella S; Karanes C; Peters W; Baynes R
Clin Infect Dis; 2001 Feb; 32(4):546-51. PubMed ID: 11181116
[TBL] [Abstract][Full Text] [Related]
5. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
[TBL] [Abstract][Full Text] [Related]
6. Performance of a hybrid central venous catheter utilized for both peripheral blood stem cell harvest and transplant support of patients undergoing autologous peripheral blood stem cell transplantation.
Restrepo A; Devore P; Encarnación CE; Wholey MH; Schneider D; Callander NS; Ferral H; Postoak D; Anderson JE; Walsh T; Padayao G; Gokmen E; Ehsan A; Ochoa L; Neumon B; West G; Restrepo MI; Przykucki J; Patterson J; Freytes CO
Bone Marrow Transplant; 2002 Sep; 30(6):389-95. PubMed ID: 12235524
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases.
Auner HW; Zebisch A; Ofner P; Sill H; Linkesch W; Krause R
Ann Hematol; 2005 Aug; 84(8):532-7. PubMed ID: 15809882
[TBL] [Abstract][Full Text] [Related]
8. Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation.
Staber PB; Holub R; Linkesch W; Schmidt H; Neumeister P
Bone Marrow Transplant; 2005 May; 35(9):889-93. PubMed ID: 15765110
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
Cutler C; Kim HT; Hochberg E; Ho V; Alyea E; Lee SJ; Fisher DC; Miklos D; Levin J; Sonis S; Soiffer RJ; Antin JH
Biol Blood Marrow Transplant; 2004 May; 10(5):328-36. PubMed ID: 15111932
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies.
Yamasaki S; Ohno Y; Taniguchi S; Yoshida T; Hayashi S; Ogawa H; Shimazaki C; Takahashi S; Kasai M; Wake A; Nishimura M; Tokunaga K; Gondo H; Takaue Y; Harada M; Mineishi S;
Bone Marrow Transplant; 2004 Feb; 33(3):279-89. PubMed ID: 14647250
[TBL] [Abstract][Full Text] [Related]
11. Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Harter C; Schulze B; Goldschmidt H; Benner A; Geiss HK; Hoppe-Tichy T; Ho AD; Egerer G
Bone Marrow Transplant; 2006 Feb; 37(4):373-9. PubMed ID: 16400334
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of peripheral blood stem cells for autologous transplantation patients with hematological malignancies: Influence of disease, mobilization method, age and sex.
Zhang C; Chen X; Zhang X; Gao L; Kong P; Wang Q; Peng X; Liu H
Transfus Apher Sci; 2008 Aug; 39(1):21-8. PubMed ID: 18599353
[TBL] [Abstract][Full Text] [Related]
13. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M
Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial.
Valteau-Couanet D; Faucher C; Aupérin A; Michon J; Milpied N; Boiron JM; Bourhis JH; Gisselbrecht C; Vernant JP; Pinna A; Bendahmane B; Delabarre F; Benhamou E
Bone Marrow Transplant; 2005 Sep; 36(6):547-52. PubMed ID: 16007101
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
[TBL] [Abstract][Full Text] [Related]
16. Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells.
Reichle A; Zaiss M; Rothe G; Schmitz G; Andreesen R
Bone Marrow Transplant; 2003 Aug; 32(3):299-305. PubMed ID: 12858202
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of nosocomial infections in adult recipients of allogeneic and autologous bone marrow and peripheral blood stem-cell transplantation.
Dettenkofer M; Ebner W; Bertz H; Babikir R; Finke J; Frank U; Rüden H; Daschner FD
Bone Marrow Transplant; 2003 May; 31(9):795-801. PubMed ID: 12732887
[TBL] [Abstract][Full Text] [Related]
18. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies.
Fernández-Avilés F; Carreras E; Urbano-Ispizua A; Rovira M; Martínez C; Gaya A; Granell M; Ramiro L; Gallego C; Hernando A; Segura S; García L; González M; Valverde M; Montserrat E
J Clin Oncol; 2006 Oct; 24(30):4855-61. PubMed ID: 17001069
[TBL] [Abstract][Full Text] [Related]
19. Infectious complications in patients receiving mobilization chemotherapy for autologous peripheral blood stem cell collection.
Jillella AP; Ustun C; Robach E; Sertkaya D; DiPiro C; Kallab AM; Brick WG; Dainer PM; Kutlar A; Townsend AR; Burgess RE
J Hematother Stem Cell Res; 2003 Apr; 12(2):155-60. PubMed ID: 12804174
[TBL] [Abstract][Full Text] [Related]
20. [Infectious complications postengrafment in the first year after autologous stem cell transplantation in children].
Ben Salah H; Coze C; Gentet JC; Lautraite C; André N; Bernard JL
Arch Pediatr; 2005 May; 12(5):526-32. PubMed ID: 15885541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
